{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"ss-31-skin","title":"SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded","body":"## What's breaking down\n\nSkin aging involves layers of cellular decline. One key layer is mitochondrial dysfunction inside skin cells. Mitochondria produce energy (ATP) and manage reactive oxygen species (ROS). With age, cardiolipin in the inner mitochondrial membrane oxidizes. This disrupts electron transport chain efficiency, lowers ATP output, raises ROS leakage, and impairs cell repair. Fibroblasts then make less collagen and elastin. The result shows up as wrinkles, sagging, slower wound healing, and reduced elasticity. SS-31 research targets this mitochondrial layer rather than surface symptoms.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. If mitochondrial cardiolipin oxidation is part of your skin aging, SS-31 binds cardiolipin directly.  \n2. Binding stabilizes the inner membrane and preserves supercomplex organization.  \n3. This improves electron transport efficiency and reduces excess ROS from existing mitochondria.  \n4. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) → mitochondrial. No siblings in scope.\n\n## What the evidence actually shows\n\nPreclinical work in aged mice shows SS-31 restores redox balance, reduces protein oxidation, and improves mitochondrial quality in heart and skeletal muscle. Human data exist for Barth syndrome (FDA approval noted in late 2025) and trials in heart failure, kidney disease, and primary mitochondrial myopathy. No published human trials test SS-31 on skin endpoints such as wrinkles, elasticity, or collagen. One 2025 mouse study explored exosome-loaded SS-31 against UV skin damage. Tier: preclinical for mitochondrial effects in general; speculative for skin.\n\n## What scientists say\n\nResearchers describe SS-31 as concentrating thousands-fold in mitochondria and stabilizing cardiolipin to support ATP production and limit ROS. Reviews note benefits in models of cardiac aging and ischemia but emphasize the need for more human data outside rare diseases. No statements claim skin-specific efficacy.\n\n## What people say on Reddit\n\nReddit threads on r/cfs and r/longevity discuss SS-31 for energy and fatigue. Users report variable energy changes, injection-site reactions, or no effect. No posts detail visible skin improvements, collagen changes, or wrinkle reduction. Anecdotal tier only.\n\n## What people say on X\n\nX posts mention SS-31 alongside other peptides for anti-aging or stock availability with skin-related compounds. One post links to a video on cellular aging reversal; none report personal before-after skin photos or measurements. Anecdotal tier only.\n\n## What we do not know\n\nDirect effects on human skin mitochondria, collagen synthesis, or visible aging markers remain untested in controlled studies. Long-term skin outcomes, optimal delivery to dermis, and interactions with topical skincare are unknown.\n\n## Safety and limits\n\nCommon reported events in trials are mild-to-moderate injection-site reactions (erythema, pruritus, pain). Human studies beyond four weeks are limited. SS-31 is FDA-approved only for Barth syndrome as of 2025; use for skin is off-label and unstudied. Individual responses vary; monitoring is advised in any research context.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ss-31-skin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"SS-31 binds cardiolipin and stabilizes the inner mitochondrial membrane.","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Core mechanism explaining potential repair focus.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No published human trials test SS-31 on skin-specific endpoints.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies evidence gap for readers researching skin.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"FDA approved elamipretide for Barth syndrome in 2025.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Current regulatory status.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Aged mice treated with SS-31 showed restored redox balance and improved mitochondrial quality.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s4"],"source_status":"sourced","why_material":"Distinguishes animal data from human data.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://lamkinclinic.com/what-peptides-improve-mitochondrial-function/","title":"What Peptides Improve Mitochondrial Function?","quote":"SS-31 binds to cardiolipin, the signature phospholipid of the inner mitochondrial membrane.","summary":"Explains cardiolipin binding mechanism.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:45:52.950Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"9170ab43cdf792b5e47b5515032ae15745507121b8135033044d578e33884fc5"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/","title":"PubMed search results for SS-31 skin","quote":"No direct skin endpoint trials returned.","summary":"Confirms absence of human skin trials.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:45:52.950Z","link_status":"ok","quote_status":"unverified","prev":"9170ab43cdf792b5e47b5515032ae15745507121b8135033044d578e33884fc5","hash":"cec68b69931979f199f0dd9df556e28a080327855f4fd0199c8f16e1505b15db"},{"id":"s3","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide","quote":"The recent FDA approval of elamipretide is for the treatment of a rare disease.","summary":"Documents 2025 approval status.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:45:52.950Z","link_status":"ok","quote_status":"unverified","prev":"cec68b69931979f199f0dd9df556e28a080327855f4fd0199c8f16e1505b15db","hash":"d87ba15d68a6f743ad8ac7f73cab6105e73cc8fa4a5af418b95f8de956122c4c"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6588449/","title":"Improving mitochondrial function with SS-31 reverses age-associated...","quote":"Treatment with SS-31 restores redox homeostasis, improves mitochondrial quality...","summary":"Mouse study on mitochondrial restoration.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:45:52.950Z","link_status":"ok","quote_status":"unverified","prev":"d87ba15d68a6f743ad8ac7f73cab6105e73cc8fa4a5af418b95f8de956122c4c","hash":"454ce0d82d8f98df8e5f958c5fbd2009a180f1f8161f9495919725f089f8038d"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:45:53.599Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded","register":"source_ledger","body":"## What's breaking down\n\nSkin aging involves layers of cellular decline. One key layer is mitochondrial dysfunction inside skin cells. Mitochondria produce energy (ATP) and manage reactive oxygen species (ROS). With age, cardiolipin in the inner mitochondrial membrane oxidizes. This disrupts electron transport chain efficiency, lowers ATP output, raises ROS leakage, and impairs cell repair. Fibroblasts then make less collagen and elastin. The result shows up as wrinkles, sagging, slower wound healing, and reduced elasticity. SS-31 research targets this mitochondrial layer rather than surface symptoms.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. If mitochondrial cardiolipin oxidation is part of your skin aging, SS-31 binds cardiolipin directly.  \n2. Binding stabilizes the inner membrane and preserves supercomplex organization.  \n3. This improves electron transport efficiency and reduces excess ROS from existing mitochondria.  \n4. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) → mitochondrial. No siblings in scope.\n\n## What the evidence actually shows\n\nPreclinical work in aged mice shows SS-31 restores redox balance, reduces protein oxidation, and improves mitochondrial quality in heart and skeletal muscle. Human data exist for Barth syndrome (FDA approval noted in late 2025) and trials in heart failure, kidney disease, and primary mitochondrial myopathy. No published human trials test SS-31 on skin endpoints such as wrinkles, elasticity, or collagen. One 2025 mouse study explored exosome-loaded SS-31 against UV skin damage. Tier: preclinical for mitochondrial effects in general; speculative for skin.\n\n## What scientists say\n\nResearchers describe SS-31 as concentrating thousands-fold in mitochondria and stabilizing cardiolipin to support ATP production and limit ROS. Reviews note benefits in models of cardiac aging and ischemia but emphasize the need for more human data outside rare diseases. No statements claim skin-specific efficacy.\n\n## What people say on Reddit\n\nReddit threads on r/cfs and r/longevity discuss SS-31 for energy and fatigue. Users report variable energy changes, injection-site reactions, or no effect. No posts detail visible skin improvements, collagen changes, or wrinkle reduction. Anecdotal tier only.\n\n## What people say on X\n\nX posts mention SS-31 alongside other peptides for anti-aging or stock availability with skin-related compounds. One post links to a video on cellular aging reversal; none report personal before-after skin photos or measurements. Anecdotal tier only.\n\n## What we do not know\n\nDirect effects on human skin mitochondria, collagen synthesis, or visible aging markers remain untested in controlled studies. Long-term skin outcomes, optimal delivery to dermis, and interactions with topical skincare are unknown.\n\n## Safety and limits\n\nCommon reported events in trials are mild-to-moderate injection-site reactions (erythema, pruritus, pain). Human studies beyond four weeks are limited. SS-31 is FDA-approved only for Barth syndrome as of 2025; use for skin is off-label and unstudied. Individual responses vary; monitoring is advised in any research context.","claims":[{"id":"c1","text":"SS-31 binds cardiolipin and stabilizes the inner mitochondrial membrane.","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Core mechanism explaining potential repair focus.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No published human trials test SS-31 on skin-specific endpoints.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies evidence gap for readers researching skin.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"FDA approved elamipretide for Barth syndrome in 2025.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Current regulatory status.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Aged mice treated with SS-31 showed restored redox balance and improved mitochondrial quality.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s4"],"source_status":"sourced","why_material":"Distinguishes animal data from human data.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://lamkinclinic.com/what-peptides-improve-mitochondrial-function/","title":"What Peptides Improve Mitochondrial Function?","quote":"SS-31 binds to cardiolipin, the signature phospholipid of the inner mitochondrial membrane.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/","title":"PubMed search results for SS-31 skin","quote":"No direct skin endpoint trials returned.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide","quote":"The recent FDA approval of elamipretide is for the treatment of a rare disease.","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6588449/","title":"Improving mitochondrial function with SS-31 reverses age-associated...","quote":"Treatment with SS-31 restores redox homeostasis, improves mitochondrial quality...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":26702,"tokens_out":2538,"cost":0.0397225,"prev_hash":"genesis","hash":"e47952f77110cf53837d06e9dd6b7a16768cb2b21ed5a34f3f4a6e6d4ee08d35"}],"provenance":[{"ts":"2026-06-29T23:45:53.599Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Skin\nSlug: ss-31-skin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"section_headings\":[\"What's breaking down\",\"Why SS-31 (Elamipretide) might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into o","response":"{\n  \"slug\": \"ss-31-skin\",\n  \"title\": \"SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded\",\n  \"body\": \"## What's breaking down\\n\\nSkin aging involves layers of cellular decline. One key layer is mitochondrial dysfunction inside skin cells. Mitochondria produce energy (ATP) and manage reactive oxygen species (ROS). With age, cardiolipin in the inner mitochondrial membrane oxidizes. This disrupts electron transport chain efficiency, lowers ATP output, raises ROS leakage, and impairs cell repair. Fibroblasts then make less collagen and elastin. The result shows up as wrinkles, sagging, slower wound healing, and reduced elasticity. SS-31 research targets this mitochondrial layer rather than surface symptoms.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. If mitochondrial cardiolipin oxidation is part of your skin aging, SS-31 binds cardiolipin directly.  \\n2. Binding stabilizes the inner membrane and preserves supercomplex organization.  \\n3. This improves electron transport efficiency and reduces excess ROS from existing mitochondria.  \\n4. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus — SS-31 (Elamipretide) → mitochondrial. No siblings in scope.\\n\\n## What the evidence actually shows\\n\\nPreclinical work in aged mice shows SS-31 restores redox balance, reduces protein oxidation, and improves mitochondrial quality in heart and skeletal muscle. Human data exist for Barth syndrome (FDA approval noted in late 2025) and trials in heart failure, kidney disease, and primary mitochondrial myopathy. No published human trials test SS-31 on skin endpoints such as wrinkles, elasticity, or collagen. One 2025 mouse study explored exosome-loaded SS-31 against UV skin damage. Tier: preclinical for mitochondrial effects in general; speculative for skin.\\n\\n## What scientists say\\n\\nResearchers describe SS-31 as","tokens_in":26702,"tokens_out":2538,"cost":0,"prev":"genesis","hash":"5a5f76574cc3a718339de8772bba3bc80353ba891e2051743bcbef8952dbf47e"},{"ts":"2026-07-17T02:42:08.138Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-skin","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5a5f76574cc3a718339de8772bba3bc80353ba891e2051743bcbef8952dbf47e","hash":"5300ffdf89b0387cca17d13259fe81c2881e2f35fe775149692419184d45e683"}],"energy":{"passes":2,"tokens_in":26702,"tokens_out":2538,"tokens_total":29240,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"5300ffdf89b0387cca17d13259fe81c2881e2f35fe775149692419184d45e683"},"posted_at":"2026-06-29T21:33:25.187Z","created_at":"2026-06-29T21:33:25.187Z","updated_at":"2026-07-17T02:42:08.138Z","machine":{"shape":"article.machine/v1","slug":"ss-31-skin","kind":"article","read":{"human":"https://miscsubjects.com/a/ss-31-skin","json":"https://miscsubjects.com/api/articles/ss-31-skin","bundle":"https://miscsubjects.com/api/articles/ss-31-skin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ss-31-skin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ss-31-skin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-skin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-skin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ss-31-skin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ss-31-skin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ss-31-skin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ss-31-skin","json":"/api/articles/ss-31-skin","markdown":"/api/articles/ss-31-skin/bundle?format=markdown","skill":"/api/articles/ss-31-skin/skill","topology":"/api/articles/ss-31-skin/topology","versions":"/api/articles/ss-31-skin/revisions","invocations":"/api/articles/ss-31-skin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ss-31-skin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"1ea11584a270062f93ac1d9e87bcb80ded82fd8354d2ed554b83770d3e105d82","object":{"object_type":"article-object","identity":{"id":"article:ss-31-skin","slug":"ss-31-skin","title":"SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/ss-31-skin","role":"explain","audience":"human"},"skill":{"route":"/api/articles/ss-31-skin/skill","role":"direct behavior","audience":"model","content":"---\nname: ss-31-skin\ndescription: Apply the SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded\n\nThis Skill is the behavioral expression of [the canonical article](/a/ss-31-skin). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/ss-31-skin.\n- Read claims and relationships at /api/articles/ss-31-skin/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Skin aging involves layers of cellular decline. One key layer is mitochondrial dysfunction inside skin cells. Mitochondria produce energy ATP and manage reactive oxygen species ROS . With age, cardiolipin in the inner m\n\n## Representations\n\n- Human: /a/ss-31-skin\n- JSON: /api/articles/ss-31-skin\n- Relationships: /api/articles/ss-31-skin/topology\n- History: /api/articles/ss-31-skin/revisions\n"},"json":{"route":"/api/articles/ss-31-skin","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/ss-31-skin/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","ss","31","skin"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/ss-31-skin/invocations?status=success","failure_events":"/api/articles/ss-31-skin/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"ss-31-skin","title":"SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded","body":"## What's breaking down\n\nSkin aging involves layers of cellular decline. One key layer is mitochondrial dysfunction inside skin cells. Mitochondria produce energy (ATP) and manage reactive oxygen species (ROS). With age, cardiolipin in the inner mitochondrial membrane oxidizes. This disrupts electron transport chain efficiency, lowers ATP output, raises ROS leakage, and impairs cell repair. Fibroblasts then make less collagen and elastin. The result shows up as wrinkles, sagging, slower wound healing, and reduced elasticity. SS-31 research targets this mitochondrial layer rather than surface symptoms.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. If mitochondrial cardiolipin oxidation is part of your skin aging, SS-31 binds cardiolipin directly.  \n2. Binding stabilizes the inner membrane and preserves supercomplex organization.  \n3. This improves electron transport efficiency and reduces excess ROS from existing mitochondria.  \n4. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) → mitochondrial. No siblings in scope.\n\n## What the evidence actually shows\n\nPreclinical work in aged mice shows SS-31 restores redox balance, reduces protein oxidation, and improves mitochondrial quality in heart and skeletal muscle. Human data exist for Barth syndrome (FDA approval noted in late 2025) and trials in heart failure, kidney disease, and primary mitochondrial myopathy. No published human trials test SS-31 on skin endpoints such as wrinkles, elasticity, or collagen. One 2025 mouse study explored exosome-loaded SS-31 against UV skin damage. Tier: preclinical for mitochondrial effects in general; speculative for skin.\n\n## What scientists say\n\nResearchers describe SS-31 as concentrating thousands-fold in mitochondria and stabilizing cardiolipin to support ATP production and limit ROS. Reviews note benefits in models of cardiac aging and ischemia but emphasize the need for more human data outside rare diseases. No statements claim skin-specific efficacy.\n\n## What people say on Reddit\n\nReddit threads on r/cfs and r/longevity discuss SS-31 for energy and fatigue. Users report variable energy changes, injection-site reactions, or no effect. No posts detail visible skin improvements, collagen changes, or wrinkle reduction. Anecdotal tier only.\n\n## What people say on X\n\nX posts mention SS-31 alongside other peptides for anti-aging or stock availability with skin-related compounds. One post links to a video on cellular aging reversal; none report personal before-after skin photos or measurements. Anecdotal tier only.\n\n## What we do not know\n\nDirect effects on human skin mitochondria, collagen synthesis, or visible aging markers remain untested in controlled studies. Long-term skin outcomes, optimal delivery to dermis, and interactions with topical skincare are unknown.\n\n## Safety and limits\n\nCommon reported events in trials are mild-to-moderate injection-site reactions (erythema, pruritus, pain). Human studies beyond four weeks are limited. SS-31 is FDA-approved only for Barth syndrome as of 2025; use for skin is off-label and unstudied. Individual responses vary; monitoring is advised in any research context.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/ss-31-skin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"SS-31 binds cardiolipin and stabilizes the inner mitochondrial membrane.","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Core mechanism explaining potential repair focus.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No published human trials test SS-31 on skin-specific endpoints.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies evidence gap for readers researching skin.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"FDA approved elamipretide for Barth syndrome in 2025.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Current regulatory status.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Aged mice treated with SS-31 showed restored redox balance and improved mitochondrial quality.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s4"],"source_status":"sourced","why_material":"Distinguishes animal data from human data.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://lamkinclinic.com/what-peptides-improve-mitochondrial-function/","title":"What Peptides Improve Mitochondrial Function?","quote":"SS-31 binds to cardiolipin, the signature phospholipid of the inner mitochondrial membrane.","summary":"Explains cardiolipin binding mechanism.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:45:52.950Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"9170ab43cdf792b5e47b5515032ae15745507121b8135033044d578e33884fc5"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/","title":"PubMed search results for SS-31 skin","quote":"No direct skin endpoint trials returned.","summary":"Confirms absence of human skin trials.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:45:52.950Z","link_status":"ok","quote_status":"unverified","prev":"9170ab43cdf792b5e47b5515032ae15745507121b8135033044d578e33884fc5","hash":"cec68b69931979f199f0dd9df556e28a080327855f4fd0199c8f16e1505b15db"},{"id":"s3","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide","quote":"The recent FDA approval of elamipretide is for the treatment of a rare disease.","summary":"Documents 2025 approval status.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:45:52.950Z","link_status":"ok","quote_status":"unverified","prev":"cec68b69931979f199f0dd9df556e28a080327855f4fd0199c8f16e1505b15db","hash":"d87ba15d68a6f743ad8ac7f73cab6105e73cc8fa4a5af418b95f8de956122c4c"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6588449/","title":"Improving mitochondrial function with SS-31 reverses age-associated...","quote":"Treatment with SS-31 restores redox homeostasis, improves mitochondrial quality...","summary":"Mouse study on mitochondrial restoration.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:45:52.950Z","link_status":"ok","quote_status":"unverified","prev":"d87ba15d68a6f743ad8ac7f73cab6105e73cc8fa4a5af418b95f8de956122c4c","hash":"454ce0d82d8f98df8e5f958c5fbd2009a180f1f8161f9495919725f089f8038d"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:45:53.599Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded","register":"source_ledger","body":"## What's breaking down\n\nSkin aging involves layers of cellular decline. One key layer is mitochondrial dysfunction inside skin cells. Mitochondria produce energy (ATP) and manage reactive oxygen species (ROS). With age, cardiolipin in the inner mitochondrial membrane oxidizes. This disrupts electron transport chain efficiency, lowers ATP output, raises ROS leakage, and impairs cell repair. Fibroblasts then make less collagen and elastin. The result shows up as wrinkles, sagging, slower wound healing, and reduced elasticity. SS-31 research targets this mitochondrial layer rather than surface symptoms.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. If mitochondrial cardiolipin oxidation is part of your skin aging, SS-31 binds cardiolipin directly.  \n2. Binding stabilizes the inner membrane and preserves supercomplex organization.  \n3. This improves electron transport efficiency and reduces excess ROS from existing mitochondria.  \n4. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) → mitochondrial. No siblings in scope.\n\n## What the evidence actually shows\n\nPreclinical work in aged mice shows SS-31 restores redox balance, reduces protein oxidation, and improves mitochondrial quality in heart and skeletal muscle. Human data exist for Barth syndrome (FDA approval noted in late 2025) and trials in heart failure, kidney disease, and primary mitochondrial myopathy. No published human trials test SS-31 on skin endpoints such as wrinkles, elasticity, or collagen. One 2025 mouse study explored exosome-loaded SS-31 against UV skin damage. Tier: preclinical for mitochondrial effects in general; speculative for skin.\n\n## What scientists say\n\nResearchers describe SS-31 as concentrating thousands-fold in mitochondria and stabilizing cardiolipin to support ATP production and limit ROS. Reviews note benefits in models of cardiac aging and ischemia but emphasize the need for more human data outside rare diseases. No statements claim skin-specific efficacy.\n\n## What people say on Reddit\n\nReddit threads on r/cfs and r/longevity discuss SS-31 for energy and fatigue. Users report variable energy changes, injection-site reactions, or no effect. No posts detail visible skin improvements, collagen changes, or wrinkle reduction. Anecdotal tier only.\n\n## What people say on X\n\nX posts mention SS-31 alongside other peptides for anti-aging or stock availability with skin-related compounds. One post links to a video on cellular aging reversal; none report personal before-after skin photos or measurements. Anecdotal tier only.\n\n## What we do not know\n\nDirect effects on human skin mitochondria, collagen synthesis, or visible aging markers remain untested in controlled studies. Long-term skin outcomes, optimal delivery to dermis, and interactions with topical skincare are unknown.\n\n## Safety and limits\n\nCommon reported events in trials are mild-to-moderate injection-site reactions (erythema, pruritus, pain). Human studies beyond four weeks are limited. SS-31 is FDA-approved only for Barth syndrome as of 2025; use for skin is off-label and unstudied. Individual responses vary; monitoring is advised in any research context.","claims":[{"id":"c1","text":"SS-31 binds cardiolipin and stabilizes the inner mitochondrial membrane.","section":"Why SS-31 (Elamipretide) might help you","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Core mechanism explaining potential repair focus.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No published human trials test SS-31 on skin-specific endpoints.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies evidence gap for readers researching skin.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"FDA approved elamipretide for Barth syndrome in 2025.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Current regulatory status.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Aged mice treated with SS-31 showed restored redox balance and improved mitochondrial quality.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s4"],"source_status":"sourced","why_material":"Distinguishes animal data from human data.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:45:53.103Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://lamkinclinic.com/what-peptides-improve-mitochondrial-function/","title":"What Peptides Improve Mitochondrial Function?","quote":"SS-31 binds to cardiolipin, the signature phospholipid of the inner mitochondrial membrane.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/","title":"PubMed search results for SS-31 skin","quote":"No direct skin endpoint trials returned.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide","quote":"The recent FDA approval of elamipretide is for the treatment of a rare disease.","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6588449/","title":"Improving mitochondrial function with SS-31 reverses age-associated...","quote":"Treatment with SS-31 restores redox homeostasis, improves mitochondrial quality...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":26702,"tokens_out":2538,"cost":0.0397225,"prev_hash":"genesis","hash":"e47952f77110cf53837d06e9dd6b7a16768cb2b21ed5a34f3f4a6e6d4ee08d35"}],"provenance":[{"ts":"2026-06-29T23:45:53.599Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Ss 31 for Skin\nSlug: ss-31-skin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"ss-31\",\"name\":\"SS-31 (Elamipretide)\",\"section_title\":\"Why SS-31 (Elamipretide) might help you\",\"layer\":\"mitochondrial\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **SS-31 (Elamipretide)** → mitochondrial\",\"section_headings\":[\"What's breaking down\",\"Why SS-31 (Elamipretide) might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into o","response":"{\n  \"slug\": \"ss-31-skin\",\n  \"title\": \"SS-31 (Elamipretide) for Skin: Mitochondrial Evidence Graded\",\n  \"body\": \"## What's breaking down\\n\\nSkin aging involves layers of cellular decline. One key layer is mitochondrial dysfunction inside skin cells. Mitochondria produce energy (ATP) and manage reactive oxygen species (ROS). With age, cardiolipin in the inner mitochondrial membrane oxidizes. This disrupts electron transport chain efficiency, lowers ATP output, raises ROS leakage, and impairs cell repair. Fibroblasts then make less collagen and elastin. The result shows up as wrinkles, sagging, slower wound healing, and reduced elasticity. SS-31 research targets this mitochondrial layer rather than surface symptoms.\\n\\n## Why SS-31 (Elamipretide) might help you\\n\\n1. If mitochondrial cardiolipin oxidation is part of your skin aging, SS-31 binds cardiolipin directly.  \\n2. Binding stabilizes the inner membrane and preserves supercomplex organization.  \\n3. This improves electron transport efficiency and reduces excess ROS from existing mitochondria.  \\n4. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus — SS-31 (Elamipretide) → mitochondrial. No siblings in scope.\\n\\n## What the evidence actually shows\\n\\nPreclinical work in aged mice shows SS-31 restores redox balance, reduces protein oxidation, and improves mitochondrial quality in heart and skeletal muscle. Human data exist for Barth syndrome (FDA approval noted in late 2025) and trials in heart failure, kidney disease, and primary mitochondrial myopathy. No published human trials test SS-31 on skin endpoints such as wrinkles, elasticity, or collagen. One 2025 mouse study explored exosome-loaded SS-31 against UV skin damage. Tier: preclinical for mitochondrial effects in general; speculative for skin.\\n\\n## What scientists say\\n\\nResearchers describe SS-31 as","tokens_in":26702,"tokens_out":2538,"cost":0,"prev":"genesis","hash":"5a5f76574cc3a718339de8772bba3bc80353ba891e2051743bcbef8952dbf47e"},{"ts":"2026-07-17T02:42:08.138Z","model":"owner","action":"voxel_divide","prompt":"","input":"ss-31-skin","response":"18 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5a5f76574cc3a718339de8772bba3bc80353ba891e2051743bcbef8952dbf47e","hash":"5300ffdf89b0387cca17d13259fe81c2881e2f35fe775149692419184d45e683"}],"energy":{"passes":2,"tokens_in":26702,"tokens_out":2538,"tokens_total":29240,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"5300ffdf89b0387cca17d13259fe81c2881e2f35fe775149692419184d45e683"},"posted_at":"2026-06-29T21:33:25.187Z","created_at":"2026-06-29T21:33:25.187Z","updated_at":"2026-07-17T02:42:08.138Z","machine":{"shape":"article.machine/v1","slug":"ss-31-skin","kind":"article","read":{"human":"https://miscsubjects.com/a/ss-31-skin","json":"https://miscsubjects.com/api/articles/ss-31-skin","bundle":"https://miscsubjects.com/api/articles/ss-31-skin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/ss-31-skin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=ss-31-skin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-skin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"ss-31-skin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/ss-31-skin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"ss-31-skin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/ss-31-skin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/ss-31-skin","json":"/api/articles/ss-31-skin","markdown":"/api/articles/ss-31-skin/bundle?format=markdown","skill":"/api/articles/ss-31-skin/skill","topology":"/api/articles/ss-31-skin/topology","versions":"/api/articles/ss-31-skin/revisions","invocations":"/api/articles/ss-31-skin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"ss-31-skin","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"1ea11584a270062f93ac1d9e87bcb80ded82fd8354d2ed554b83770d3e105d82"}}}